Doctor of Medicine

Jerome Zeldis, M.D., Ph.D, Appointed as Executive Chair of ViralClear Pharmaceuticals, Inc.

Retrieved on: 
Tuesday, March 31, 2020
Academic degrees, Qualifications, Doctor of Medicine, Higher education, Guggenheim Fellows

Jerome (Jerry) Zeldis, M.D., Ph.D brings extensive life sciences experience gained primarily through his career at Celgene, Inc.

Key Points: 
  • Jerome (Jerry) Zeldis, M.D., Ph.D brings extensive life sciences experience gained primarily through his career at Celgene, Inc.
  • I look forward to pursuing development of Vicromax(tm) and contributing my knowledge and expertise to this important initiative.
  • He attended Brown University for an AB, MS, followed by Yale University for an M Phil, MD, PhD in Molecular Biophysics and Biochemistry.
  • Investors and security holders are urged to read these documents free of charge on the SECs website at http://www.sec.gov.

First Patient Enrolled in the US STEP-1 Clinical Trial of EndoBarrier at Michigan Medicine

Retrieved on: 
Tuesday, January 28, 2020
Biotechnology, FDA, Health, Pharmaceutical, Clinical trials, Academic degrees, Health, Qualifications, Clinical research, Pharmaceutical industry, Clinical pharmacology, Clinical trial, Design of experiments, Doctor of Medicine, Medicine

Michigan Medicine is one of five clinical study sites for the STEP-1 trial; the site is led by principal investigator Allison R. Schulman M.D., M.P.H., assistant professor of gastroenterology and internal medicine.

Key Points: 
  • Michigan Medicine is one of five clinical study sites for the STEP-1 trial; the site is led by principal investigator Allison R. Schulman M.D., M.P.H., assistant professor of gastroenterology and internal medicine.
  • We are honored to be the first clinical study site to enroll the first patient into the STEP-1 trial, said Dr. Schulman.
  • The STEP-1 trial is the randomized (3 EndoBarrier: 1 Control) controlled, double-blinded pivotal trial of EndoBarrier in the U.S.
  • The five clinical trial sites include Brigham and Womens Hospital, Michigan Medicine, Baylor College of Medicine, Thomas Jefferson University and Surgical Specialists of Louisiana.

Lianping Weng M.D., Joins The Oncology Institute of Hope and Innovation

Retrieved on: 
Friday, January 24, 2020
Academic degrees, Qualifications, Education, Wannan Medical College, Fellowship, Wuhu, Doctor of Medicine, Internal medicine

CERRITOS, Calif., Jan. 24, 2020 /PRNewswire-PRWeb/ --The Oncology Institute of Hope and Innovation welcomes Lianping Weng M.D., to their team of specialists.

Key Points: 
  • CERRITOS, Calif., Jan. 24, 2020 /PRNewswire-PRWeb/ --The Oncology Institute of Hope and Innovation welcomes Lianping Weng M.D., to their team of specialists.
  • Dr. Liangping Weng graduated with his Doctor of Medicine from Wannan Medical College in Wuhu, Anhui, China.
  • He completed his residency in Internal Medicine from Mount Vernon Hospital in New York and his fellowship in Hematology/Oncology from Boston Medical Center in Boston Massachusetts.
  • Dr. Liangping Weng is a dedicated physician who believes the most important aspect of cancer treatment is compassion and education.

Incyte Names New Member to Its Board of Directors

Retrieved on: 
Thursday, December 19, 2019
Biotechnology, Health, Science, Pharmaceutical, Research, Academic degrees, Qualifications, Incyte, Harrigan, Doctor of Medicine

Incyte (Nasdaq:INCY) announces the appointment of Edmund P. Harrigan, M.D., as a new member of the Board of Directors, effective December 16, 2019.

Key Points: 
  • Incyte (Nasdaq:INCY) announces the appointment of Edmund P. Harrigan, M.D., as a new member of the Board of Directors, effective December 16, 2019.
  • We are delighted to welcome Edmund to Incyte.
  • It is an exciting time to be joining Incyte as the company strives to advance clinical candidates from its diverse portfolio, said Dr. Harrigan.
  • For additional information on Incyte, please visit Incyte.com and follow @Incyte .

D.G. Sebesta, MD, FACS is being recognized by Continental Who's Who

Retrieved on: 
Monday, September 16, 2019
Academic degrees, Sebesta, Doctor of Medicine, Perelman School of Medicine at the University of Pennsylvania

Sebesta, MD, FACS is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as a Surgeon at Othello Community Hospital and North Valley Hospital.

Key Points: 
  • Sebesta, MD, FACS is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as a Surgeon at Othello Community Hospital and North Valley Hospital.
  • A frontrunner in healthcare, Dr. Sebesta has over fifty-six years of surgical experience.
  • People say that Dr. Sebesta has charm and warmth; he receives hugs at any Walmart in Washington State.
  • Throughout his education and training, Dr. Sebesta earned a Doctorate of Medicine from the Perelman School of Medicine at the University of Pennsylvania.

MSAA Announces New Chief Medical Officer

Retrieved on: 
Wednesday, July 17, 2019
Academic degrees, Education, Medical school, Doctor of Medicine, Banner University Medical Center Tucson

CHERRY HILL, N.J., July 17, 2019 /PRNewswire/ --The Multiple Sclerosis Association of America (MSAA) is proud to announce a new Chief Medical Officer (CMO) for the organization.

Key Points: 
  • CHERRY HILL, N.J., July 17, 2019 /PRNewswire/ --The Multiple Sclerosis Association of America (MSAA) is proud to announce a new Chief Medical Officer (CMO) for the organization.
  • He also holds the position of director of the Multiple Sclerosis Clinic at Banner University Medical Center and is a clinical professor of neurology at the University of Arizona Medical School.
  • Dr. Hendin earned his undergraduate degree at Washington University and his Medical Doctorate (MD) degree at Washington University Medical School.
  • He has had seven academic appointments, largely at Washington University Medical School and Arizona Medical School.

Alice Reier, MD is recognized by Continental Who's Who

Retrieved on: 
Tuesday, April 23, 2019
Academic degrees, Education, Doctor of Medicine, Higher education

EMERYVILLE, Calif., April 23, 2019 /PRNewswire/ -- Alice Reier, MD is recognized by the Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as an Oncologist at her Private Practice.

Key Points: 
  • EMERYVILLE, Calif., April 23, 2019 /PRNewswire/ -- Alice Reier, MD is recognized by the Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as an Oncologist at her Private Practice.
  • Working diligently in her field since her fellowship in 1998, Alice C. Reier, MD, is a highly-regarded oncologist with a private practice in Oakland, California.
  • Throughout her education and training, Dr. Reier graduated from UC Berkeley with a Bachelors Degree and received her Doctorate of Medicine (MD) at the Medical College of Wisconsin in Milwaukee.
  • Renowned amongst her peers, Dr. Reier is the recipient of the Best Doctor Award from 2010 until 2012.

Doctors Without Jobs Says Recent Residency Match Leaves More U.S. Physicians Jobless

Retrieved on: 
Monday, April 22, 2019
Academic degrees, Medical education in the United States, Education, Health, Medical education, Physicians, Residency, Medical school, Doctor of Medicine, Doctors

"In recent years, about six percent of U.S. medical school graduates have not moved into residencies each year," says Kevin Lynn, Founder of Doctors without Jobs.

Key Points: 
  • "In recent years, about six percent of U.S. medical school graduates have not moved into residencies each year," says Kevin Lynn, Founder of Doctors without Jobs.
  • Last month, 44,600 doctors registered for the 2019 Main Residency Match which pairs current and prior year med school graduates with residencies.
  • "But we can't continue to leave our U.S. medical doctors shut out of their professions; we must prioritize hiring our U.S. doctors before importing doctors.
  • Doctors without Jobs explores why some U.S. citizen medical school graduates in good standing do not match to residencies and seeks to build awareness of the issue and find solutions.

Thomas Jefferson University Helps Launch World's First International Medical Degree

Retrieved on: 
Monday, November 12, 2018
Education, V-12 Navy College Training Program, Medical education in the United States, Health education, Market East, Philadelphia, Academic titles, Thomas Jefferson University, Medical school, Doctor of Medicine, Università Cattolica del Sacro Cuore, Academic degree, Clinical clerkship

Under the terms of the partnership, medical students at Catholic University of the Sacred Heart in Rome could earn a Bachelor of Science degree from Jefferson and Doctor of Medicine degrees from the Sidney Kimmel Medical College at Thomas Jefferson University and from The School of Medicine and Surgery at Catholic University in Rome all within just six years.

Key Points: 
  • Under the terms of the partnership, medical students at Catholic University of the Sacred Heart in Rome could earn a Bachelor of Science degree from Jefferson and Doctor of Medicine degrees from the Sidney Kimmel Medical College at Thomas Jefferson University and from The School of Medicine and Surgery at Catholic University in Rome all within just six years.
  • In the U.S., students must earn a four-year undergraduate degree and then a four-year medical degree to practice medicine.
  • Catholic University medical students who select the English track will have the opportunity to travel to Thomas Jefferson University to meet the United States' undergraduate requirements needed to pursue a medical degree.
  • Leadership from Thomas Jefferson University, Catholic University and Gemelli University Hospital, where medical school rotations occur, gathered here Sunday to sign a definitive agreement to formalize the program.

Benitec Biopharma Announces the Appointment of Gregory R. Reyes, M.D., Ph.D. as Senior Scientific Advisor

Retrieved on: 
Wednesday, September 19, 2018
Health, Education, Economy of the United States, Celgene, Summit, New Jersey, Schering-Plough, Pfizer, Doctor of Medicine, Schering

As the Senior Scientific Advisor, Dr. Reyes will lead the Company's efforts to advance and expand its portfolio of gene therapy products.

Key Points: 
  • As the Senior Scientific Advisor, Dr. Reyes will lead the Company's efforts to advance and expand its portfolio of gene therapy products.
  • He has held senior leadership roles at Pfizer, Schering-Plough, and prior to joining Benitec Biopharma, Dr. Reyes held the position of Senior Vice President, Drug Discovery & Site Head at Celgene Corporation.
  • Gregory R. Reyes, M.D., Ph.D., Senior Scientific Advisor, commented, "Benitec is clearly on the threshold of important and exciting promise from its research with its current, clinical stage oncology program and its broader collaboration agreement with Axovant.
  • For further information regarding Benitec and its activities, please contact the persons below, or visit the Benitec website at www.benitec.com .